SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAPUTO, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.831
EU - Europa 3.316
AS - Asia 1.581
SA - Sud America 16
AF - Africa 7
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.758
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.811
PL - Polonia 1.724
CN - Cina 729
IT - Italia 439
SG - Singapore 439
UA - Ucraina 402
TR - Turchia 293
DE - Germania 284
GB - Regno Unito 163
SE - Svezia 87
FI - Finlandia 84
ID - Indonesia 52
BE - Belgio 35
VN - Vietnam 34
CA - Canada 20
NL - Olanda 20
RU - Federazione Russa 19
BR - Brasile 15
CZ - Repubblica Ceca 13
FR - Francia 12
IN - India 11
IR - Iran 8
LT - Lituania 8
RO - Romania 7
AT - Austria 6
IE - Irlanda 6
HK - Hong Kong 5
ZA - Sudafrica 4
AU - Australia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CH - Svizzera 2
ES - Italia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
EG - Egitto 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
RS - Serbia 1
TN - Tunisia 1
Totale 11.758
Salva come PNG Salva come JPEG
Città #
Warsaw 1.724
Fairfield 948
Woodbridge 759
Houston 549
Ashburn 453
Santa Clara 406
Jacksonville 401
Chandler 369
Seattle 367
Ann Arbor 342
Wilmington 341
Cambridge 328
Singapore 291
Izmir 237
Ferrara 180
Princeton 173
Beijing 163
Nanjing 161
San Diego 107
New York 101
Shanghai 62
Milan 53
Jakarta 52
Los Angeles 45
Boardman 42
Nanchang 41
Bologna 39
Shenyang 37
Hebei 36
Brussels 35
Dong Ket 34
Jiaxing 33
Tianjin 30
Changsha 28
Dearborn 27
Falls Church 24
London 22
Norwalk 22
Jinan 21
Mountain View 21
Helsinki 18
Orange 18
Rome 18
Redwood City 17
Falkenstein 15
San Mateo 15
Kunming 14
Modena 14
Auburn Hills 12
Brno 12
Des Moines 12
Munich 12
Ningbo 12
Ottawa 11
Taizhou 10
Ferrara di Monte Baldo 9
Toronto 9
Washington 9
San Bonifacio 8
Ardabil 7
Leawood 7
Phoenix 7
Changchun 6
Dublin 6
Frankfurt am Main 6
Hangzhou 6
Lanzhou 6
Monmouth Junction 6
Zhengzhou 6
Addison 5
Augusta 5
Bremen 5
Nuremberg 5
Philadelphia 5
Verona 5
Andover 4
Dronten 4
Guangzhou 4
Hong Kong 4
New Bedfont 4
Vienna 4
Bucharest 3
Chicago 3
Easton 3
Fuzhou 3
Haikou 3
Novosibirsk 3
Prescot 3
Pune 3
Tappahannock 3
Amsterdam 2
Anzola 2
Arezzo 2
Berlin 2
Borgo Val di Taro 2
Brescia 2
Casalnuovo di Napoli 2
Chengdu 2
Council Bluffs 2
Gorle 2
Totale 9.513
Salva come PNG Salva come JPEG
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 267
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice 260
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 233
Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS tat-based vaccines 218
Candidate HIV-1 Tat vaccine development: From basic science to clinical trials 218
HIV-1 tat addresses dendritic cells to induce a predominant th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection 217
The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: Findings in a cohort of HIV-1 seroconverters 208
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys 206
null 183
null 179
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 175
null 167
Nanoparticles for delivery of a pharmacologically active agent 164
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 162
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 161
Recombinant herpes simplex virus and uses therefor 158
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 156
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 137
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 136
Transformation of hamster kidney cells by fragments of BK virus DNA 130
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 125
Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice 115
Cooperation in oncogenesis between BK virus early region gene and the activated human c-Harvey RAS oncogene 115
null 113
Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment 112
null 110
Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane 109
Containment of infection in Tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6Pcy243 109
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 107
Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model 107
null 104
Episomal DNA of a BK virus variant in a human insulinoma 103
null 103
null 101
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 100
Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells 100
Recent Advances In The Development Of HIV-1 Tat-Based Vaccines 98
Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients 98
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 96
null 95
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 94
null 94
null 91
null 90
Complex associates of plasmid DNA and a novel class of block copolymers with PEG and cationic segments as new vectors for gene delivery 90
null 90
The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells 89
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 88
The HIV-1 regulatory genes tat and rev as targets for gene therapy 87
null 87
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes. 87
null 86
null 85
null 83
Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination 83
EFFECT OF TAT TRANSDOMINANT NEGATIVE MUTANTS ON HIV-1 REPLICATION IN JURKAT T-CELL LINES 82
The tat gene and protein of the human immunodeficiency virus type 1. 82
null 81
null 79
null 79
Expression of hepatitis B surface antigen in human cells by a recombinant BK virus DNA vector 77
Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region 75
null 75
Reexamination of the coding potential of the HTLV-1 pX region 75
DNA immunization with HIV-1 tat mutated in the transactivation domain induces humoral and cellular immune response against wild-type Tat 74
Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens 74
Naïve CD8+ T-Cells Engage a Versatile Metabolic Program Upon Activation in Humans and Differ Energetically From Memory CD8+ T-Cells 74
null 72
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P) 72
The HIV-1 tat gene as a target for gene therapy and analysis of its role in cell proliferation. 70
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 70
New BK virus episomal vector for complementary DNA expression in human cells 70
Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes 70
Induction of anti-Tat immune response in mice following inoculation of plasmid DNA expressing HIV-tat mutant genes. 69
Transformation of Hamster kidney cells by a fragment of BK virus DNA containing the entire early region. 69
Core-shell microspheres by dispersion polymerization as promising delivery systems for proteins 68
Interaction of Sp1 transcription factor with HIV-1 Tat protein: Looking for cellular partners 68
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles 67
Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application 67
Induzione di una risposta immune in topi immunizzati con DNA plasmidici codificanti due mutanti transdominanti negativi del gene tat di HIV-1. 66
Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication 66
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment 66
Functional polymeric nano/microparticles for surface adsorption and delivery of protein and DNA vaccines 65
Formation of oligomeric free BK virus DNA is required for tandem integration of viral genomes into cellular DNA 64
The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells 64
Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules 63
HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials 63
Pentosan Polysulfate as an Inhibitor of Extracellular HIV-1 Tat 63
The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice 61
The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein 61
Presenza del virus BK in sarcomi di Kaposi. 60
Characterization of the effects of two polysulfonated distamycin A derivatives, PNU145156E and PNU153429, on HIV type 1 Tat protein 58
Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine 58
Oncogenicity of BK virus for immunosuppressed hamster 56
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 55
Hpv-specific systemic antibody responses and memory b cells are independently maintained up to 6 years and in a vaccine-specific manner following immunization with cervarix and gardasil in adolescent and young adult women in vaccination programs in Italy 54
HIV-1 Tat mutants in the cysteine-rich region down-regulate HLA class II expression in T lymphocytic and macrophage cell lines 52
Studi sulle interrelazioni tra il virus BK e i tumori insulinari 52
Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8+ T Cells in Elderly Humans 51
null 50
Totale 10.186
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.977
Totale 64.352
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.089 0 0 0 0 0 0 0 269 238 332 159 91
2020/20211.767 165 150 142 156 111 153 109 219 72 237 157 96
2021/20221.319 38 111 73 82 29 53 68 114 61 115 106 469
2022/2023933 140 37 54 103 130 118 59 97 113 9 47 26
2023/2024644 63 80 33 23 44 143 25 36 20 17 11 149
2024/20251.220 91 70 240 100 332 225 114 48 0 0 0 0
Totale 11.999